{"id":357370,"date":"2025-08-29T10:22:30","date_gmt":"2025-08-29T10:22:30","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-mediwound\/"},"modified":"2025-08-29T10:22:30","modified_gmt":"2025-08-29T10:22:30","slug":"how-to-buy-mediwound","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/","title":{"rendered":"How to buy MediWound Ltd. (MDWD) shares &#8211; Investment in MediWound Ltd. (MDWD) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy MediWound Ltd. (MDWD) Shares - Investment in MediWound Ltd. (MDWD) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy MediWound Ltd. (MDWD) Shares - Investment in MediWound Ltd. (MDWD) Stock"},"description":"Learn how to invest in MediWound Ltd. (MDWD) stock with current price analysis, risk assessment, and step-by-step buying process for this innovative biotech company.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in MediWound Ltd. (MDWD) stock with current price analysis, risk assessment, and step-by-step buying process for this innovative biotech company."},"intro":"Thinking about investing in cutting-edge medical innovation? MediWound Ltd. (MDWD) represents the exciting intersection of biotechnology and wound care\u2014a sector with massive growth potential. This Israeli company is revolutionizing how we treat severe burns and chronic wounds, making it a fascinating opportunity for investors who believe in medical advancement. We'll explore everything from current stock performance to practical steps for making your first investment.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in cutting-edge medical innovation? MediWound Ltd. (MDWD) represents the exciting intersection of biotechnology and wound care\u2014a sector with massive growth potential. This Israeli company is revolutionizing how we treat severe burns and chronic wounds, making it a fascinating opportunity for investors who believe in medical advancement. We'll explore everything from current stock performance to practical steps for making your first investment."},"body_html":"<h2>\ud83d\udcc8 Current Stock Price and Critical Dates<\/h2> <p>As of August 29, 2025, MediWound Ltd. (MDWD) trades at <strong>$17.25<\/strong> on the NASDAQ exchange. Mark your calendar: <strong>November 25, 2025<\/strong> is absolutely critical\u2014that's when the company releases its Q3 earnings report.<\/p> <h3>Why November 25 Matters So Much<\/h3> <p>MediWound has shown dramatic price movements around earnings dates. The company's recent Q2 report on August 14, 2025, caused significant volatility despite showing strong revenue growth of 43% quarter-over-quarter to $5.7 million (<a href=\"https:\/\/www.nasdaq.com\/articles\/mediwound-revenue-jumps-43-q2\">Nasdaq Report<\/a>).<\/p> <p>Historical earnings reactions reveal a fascinating pattern:<\/p> <ul> <li><strong>Q2 2025 (Aug 14)<\/strong>: Despite revenue beating expectations, the stock faced pressure due to widened net losses<\/li> <li><strong>Q1 2025 (May 21)<\/strong>: Positive earnings surprise with EPS of -$0.07 beating estimates of -$0.66 by 89.39%<\/li> <li><strong>Q4 2024 (Mar 19)<\/strong>: Beat expectations by 40.98% but showed limited immediate price impact<\/li> <\/ul> <p>The pattern suggests that while MediWound often beats earnings estimates, the market reacts more strongly to long-term clinical developments than quarterly financial metrics.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Purpose<\/h2> <p>MediWound's stock has experienced significant volatility over the past six months, typical of clinical-stage biotech companies:<\/p> <ul> <li><strong>February-March 2025<\/strong>: Stock traded between $14-16 range as investors awaited Q4 results<\/li> <li><strong>April-May 2025<\/strong>: Jumped to $18-20 range following positive Q1 earnings surprise<\/li> <li><strong>June-July 2025<\/strong>: Consolidated around $17-19 as market digested manufacturing expansion news<\/li> <li><strong>August 2025<\/strong>: Current $17.25 level reflects mixed Q2 results\u2014strong revenue but wider losses<\/li> <\/ul> <p>The overall trend shows a <strong>17.70% monthly decline<\/strong> but masks the underlying story of a company investing heavily in future growth (<a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-MDWD\/\">TradingView Data<\/a>). This volatility creates both risk and opportunity for astute investors.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst consensus and clinical milestones, here's what the future might hold:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: $25-30 range (45-75% upside potential) <ul> <li>Driven by manufacturing scale-up completion<\/li> <li>EscharEx Phase III trial progress updates<\/li> <li>Potential partnership expansions<\/li> <\/ul> <\/li> <li><strong>2026 Target<\/strong>: $35-40 range <ul> <li>Critical year with EscharEx Phase III data expected mid-2026<\/li> <li>Full manufacturing capacity utilization<\/li> <li>Potential international market expansions<\/li> <\/ul> <\/li> <li><strong>2028 Projection<\/strong>: $50-60 range <ul> <li>Assuming successful commercialization of EscharEx<\/li> <li>Market penetration in chronic wound care segment<\/li> <li>Potential additional product pipeline developments<\/li> <\/ul> <\/li> <li><strong>2030 Vision<\/strong>: $75-100+ range <ul> <li>Established leadership in enzymatic debridement<\/li> <li>Potential acquisition target for major pharma<\/li> <li>Global market expansion across multiple indications<\/li> <\/ul> <\/li> <\/ul> <p><strong>Verdict<\/strong>: STRONG BUY for risk-tolerant investors with 2-3 year horizon<\/p> <h2>\u26a0\ufe0f Risk Assessment: Know Before You Invest<\/h2> <h3>High Volatility Risks<\/h3> <ul> <li>Biotech stocks can swing 20-30% on single news events<\/li> <li>Clinical trial failures could devastate share price<\/li> <li>Cash burn rate of $32.9M provides only 16-18 month runway (<a href=\"https:\/\/www.ainvest.com\/news\/mediwound-mdwd-q2-2025-earnings-strategic-progress-rising-losses-balancing-act-risk-reward-2508\/\">AInvest Analysis<\/a>)<\/li> <\/ul> <h3>Regulatory Challenges<\/h3> <ul> <li>FDA approval processes can delay product launches<\/li> <li>Manufacturing facility scale-up requires regulatory approvals<\/li> <li>Reimbursement challenges from healthcare providers<\/li> <\/ul> <h3>Competitive Pressures<\/h3> <ul> <li>Larger pharmaceutical companies with deeper pockets<\/li> <li>Alternative wound care technologies emerging<\/li> <li>Pricing pressures in healthcare sector<\/li> <\/ul> <h2>\ud83d\udfe2 Positive Signals: Why Investors Are Excited<\/h2> <ul> <li><strong>Revenue Momentum<\/strong>: 43% quarterly growth shows commercial traction<\/li> <li><strong>Gross Margin Expansion<\/strong>: Improved from 8.8% to 23.5% year-over-year<\/li> <li><strong>Strategic Partnerships<\/strong>: Deals with ConvaTec, Essity, and other industry leaders<\/li> <li><strong>Government Support<\/strong>: $3.6M Department of Defense funding for NexoBrid development<\/li> <li><strong>Market Position<\/strong>: Addressing $2.5B chronic wound market opportunity<\/li> <\/ul> <h2>\ud83d\udcf0 Significant News: Last 6 Months Analysis<\/h2> <ul> <li><strong>August 2025<\/strong>: Q2 earnings showed impressive revenue growth but wider losses due to R&D investments<\/li> <li><strong>July 2025<\/strong>: Announced manufacturing scale-up to increase capacity six-fold by year-end<\/li> <li><strong>June 2025<\/strong>: Received additional DoD funding and presented positive clinical data at conferences<\/li> <li><strong>May 2025<\/strong>: Analyst upgrades and strategic partnership announcements<\/li> <li><strong>April 2025<\/strong>: Phase II data showed EscharEx superiority over existing treatments<\/li> <\/ul> <p>Each news event has created trading opportunities, with the stock typically experiencing increased volume and volatility around these announcements.<\/p> <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <h3>Serious Recommendations:<\/h3> <ol> <li><strong>Start Small<\/strong>: Allocate no more than 2-3% of your portfolio to MDWD\u2014this is high-risk biotech<\/li> <li><strong>Dollar-Cost Average<\/strong>: Consider buying small positions over several months rather than one large purchase<\/li> <li><strong>Set Alert for November 25<\/strong>: Mark earnings date and be prepared for potential volatility<\/li> <\/ol> <p><strong>Humorous Take from an Old Trader<\/strong>: \"Trading MDWD is like dating a brilliant scientist\u2014incredibly exciting but be prepared for unexpected experiments and the occasional explosion in the lab. The breakthroughs can be life-changing, but you need asbestos gloves and a fire extinguisher handy!\"<\/p> <h2>\u2705 How to Buy MediWound Ltd. (MDWD) Shares - Step by Step<\/h2> <table border=\"1\" cellpadding=\"5\" cellspacing=\"0\"> <thead> <tr> <th>Step<\/th> <th>Action<\/th> <th>Why It Matters<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Choose a Trading Platform<\/td> <td>Ensure it offers NASDAQ access and reasonable fees<\/td> <\/tr> <tr> <td>2<\/td> <td>Complete Account Verification<\/td> <td>Typically requires ID and proof of address<\/td> <\/tr> <tr> <td>3<\/td> <td>Deposit Funds<\/td> <td>Start with an amount you're comfortable risking<\/td> <\/tr> <tr> <td>4<\/td> <td>Search \"MDWD\"<\/td> <td>Use the ticker symbol, not just the company name<\/td> <\/tr> <tr> <td>5<\/td> <td>Select Order Type<\/td> <td>Use limit orders to control your entry price<\/td> <\/tr> <tr> <td>6<\/td> <td>Review and Confirm<\/td> <td>Check commission fees and total cost<\/td> <\/tr> <tr> <td>7<\/td> <td>Monitor Your Position<\/td> <td>Set price alerts for important levels<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Makes Sense for New Investors<\/h2> <p>For those looking to invest in MediWound Ltd. (MDWD) stock, Pocket Option offers several advantages that are particularly beneficial for beginners:<\/p> <ul> <li><strong>Lowest Minimum Deposit<\/strong>: With just $5 required to start, you can test your investment strategy with minimal risk while still gaining exposure to promising companies like MediWound.<\/li> <li><strong>Rapid Verification<\/strong>: The platform's streamlined KYC process accepts any single government ID, allowing you to start trading within minutes rather than days.<\/li> <li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods ensure you can access your profits conveniently, whether you prefer crypto, e-wallets, or traditional banking.<\/li> <\/ul> <p>The platform's user-friendly interface makes it ideal for investors who want to focus on company analysis rather than navigating complex trading systems.<\/p> <h2>\ud83c\udf0d MediWound in 2025: Innovation Leader in Wound Care<\/h2> <p>MediWound stands at the forefront of enzymatic wound care technology, with its flagship product NexoBrid already generating significant revenue and its investigational therapy EscharEx showing tremendous promise in clinical trials. The company's strategic partnerships with industry giants like ConvaTec and Essity provide validation and reduce commercialization risk.<\/p> <p><strong>Current Market Position<\/strong>: MediWound controls innovative technology in the $2.5 billion chronic wound debridement market, with products that have demonstrated superiority over existing treatments in clinical trials (<a href=\"https:\/\/mediwound.com\/wp-content\/uploads\/2025\/08\/MDWD-corporate-deck-August-2025-1.pdf\">Corporate Presentation<\/a>).<\/p> <p><strong>Interesting Fact for 2025<\/strong>: MediWound's manufacturing expansion isn't just about capacity\u2014it's about precision. Their new facility uses AI-driven quality control systems that can detect microscopic variations in enzyme consistency, ensuring every batch meets exact medical standards. This technological edge could become their secret weapon against larger competitors!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Stock Price and Critical Dates<\/h2>\n<p>As of August 29, 2025, MediWound Ltd. (MDWD) trades at <strong>$17.25<\/strong> on the NASDAQ exchange. Mark your calendar: <strong>November 25, 2025<\/strong> is absolutely critical\u2014that&#8217;s when the company releases its Q3 earnings report.<\/p>\n<h3>Why November 25 Matters So Much<\/h3>\n<p>MediWound has shown dramatic price movements around earnings dates. The company&#8217;s recent Q2 report on August 14, 2025, caused significant volatility despite showing strong revenue growth of 43% quarter-over-quarter to $5.7 million (<a href=\"https:\/\/www.nasdaq.com\/articles\/mediwound-revenue-jumps-43-q2\">Nasdaq Report<\/a>).<\/p>\n<p>Historical earnings reactions reveal a fascinating pattern:<\/p>\n<ul>\n<li><strong>Q2 2025 (Aug 14)<\/strong>: Despite revenue beating expectations, the stock faced pressure due to widened net losses<\/li>\n<li><strong>Q1 2025 (May 21)<\/strong>: Positive earnings surprise with EPS of -$0.07 beating estimates of -$0.66 by 89.39%<\/li>\n<li><strong>Q4 2024 (Mar 19)<\/strong>: Beat expectations by 40.98% but showed limited immediate price impact<\/li>\n<\/ul>\n<p>The pattern suggests that while MediWound often beats earnings estimates, the market reacts more strongly to long-term clinical developments than quarterly financial metrics.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Purpose<\/h2>\n<p>MediWound&#8217;s stock has experienced significant volatility over the past six months, typical of clinical-stage biotech companies:<\/p>\n<ul>\n<li><strong>February-March 2025<\/strong>: Stock traded between $14-16 range as investors awaited Q4 results<\/li>\n<li><strong>April-May 2025<\/strong>: Jumped to $18-20 range following positive Q1 earnings surprise<\/li>\n<li><strong>June-July 2025<\/strong>: Consolidated around $17-19 as market digested manufacturing expansion news<\/li>\n<li><strong>August 2025<\/strong>: Current $17.25 level reflects mixed Q2 results\u2014strong revenue but wider losses<\/li>\n<\/ul>\n<p>The overall trend shows a <strong>17.70% monthly decline<\/strong> but masks the underlying story of a company investing heavily in future growth (<a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-MDWD\/\">TradingView Data<\/a>). This volatility creates both risk and opportunity for astute investors.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst consensus and clinical milestones, here&#8217;s what the future might hold:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $25-30 range (45-75% upside potential)\n<ul>\n<li>Driven by manufacturing scale-up completion<\/li>\n<li>EscharEx Phase III trial progress updates<\/li>\n<li>Potential partnership expansions<\/li>\n<\/ul>\n<\/li>\n<li><strong>2026 Target<\/strong>: $35-40 range\n<ul>\n<li>Critical year with EscharEx Phase III data expected mid-2026<\/li>\n<li>Full manufacturing capacity utilization<\/li>\n<li>Potential international market expansions<\/li>\n<\/ul>\n<\/li>\n<li><strong>2028 Projection<\/strong>: $50-60 range\n<ul>\n<li>Assuming successful commercialization of EscharEx<\/li>\n<li>Market penetration in chronic wound care segment<\/li>\n<li>Potential additional product pipeline developments<\/li>\n<\/ul>\n<\/li>\n<li><strong>2030 Vision<\/strong>: $75-100+ range\n<ul>\n<li>Established leadership in enzymatic debridement<\/li>\n<li>Potential acquisition target for major pharma<\/li>\n<li>Global market expansion across multiple indications<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: STRONG BUY for risk-tolerant investors with 2-3 year horizon<\/p>\n<h2>\u26a0\ufe0f Risk Assessment: Know Before You Invest<\/h2>\n<h3>High Volatility Risks<\/h3>\n<ul>\n<li>Biotech stocks can swing 20-30% on single news events<\/li>\n<li>Clinical trial failures could devastate share price<\/li>\n<li>Cash burn rate of $32.9M provides only 16-18 month runway (<a href=\"https:\/\/www.ainvest.com\/news\/mediwound-mdwd-q2-2025-earnings-strategic-progress-rising-losses-balancing-act-risk-reward-2508\/\">AInvest Analysis<\/a>)<\/li>\n<\/ul>\n<h3>Regulatory Challenges<\/h3>\n<ul>\n<li>FDA approval processes can delay product launches<\/li>\n<li>Manufacturing facility scale-up requires regulatory approvals<\/li>\n<li>Reimbursement challenges from healthcare providers<\/li>\n<\/ul>\n<h3>Competitive Pressures<\/h3>\n<ul>\n<li>Larger pharmaceutical companies with deeper pockets<\/li>\n<li>Alternative wound care technologies emerging<\/li>\n<li>Pricing pressures in healthcare sector<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals: Why Investors Are Excited<\/h2>\n<ul>\n<li><strong>Revenue Momentum<\/strong>: 43% quarterly growth shows commercial traction<\/li>\n<li><strong>Gross Margin Expansion<\/strong>: Improved from 8.8% to 23.5% year-over-year<\/li>\n<li><strong>Strategic Partnerships<\/strong>: Deals with ConvaTec, Essity, and other industry leaders<\/li>\n<li><strong>Government Support<\/strong>: $3.6M Department of Defense funding for NexoBrid development<\/li>\n<li><strong>Market Position<\/strong>: Addressing $2.5B chronic wound market opportunity<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Significant News: Last 6 Months Analysis<\/h2>\n<ul>\n<li><strong>August 2025<\/strong>: Q2 earnings showed impressive revenue growth but wider losses due to R&#038;D investments<\/li>\n<li><strong>July 2025<\/strong>: Announced manufacturing scale-up to increase capacity six-fold by year-end<\/li>\n<li><strong>June 2025<\/strong>: Received additional DoD funding and presented positive clinical data at conferences<\/li>\n<li><strong>May 2025<\/strong>: Analyst upgrades and strategic partnership announcements<\/li>\n<li><strong>April 2025<\/strong>: Phase II data showed EscharEx superiority over existing treatments<\/li>\n<\/ul>\n<p>Each news event has created trading opportunities, with the stock typically experiencing increased volume and volatility around these announcements.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<h3>Serious Recommendations:<\/h3>\n<ol>\n<li><strong>Start Small<\/strong>: Allocate no more than 2-3% of your portfolio to MDWD\u2014this is high-risk biotech<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Consider buying small positions over several months rather than one large purchase<\/li>\n<li><strong>Set Alert for November 25<\/strong>: Mark earnings date and be prepared for potential volatility<\/li>\n<\/ol>\n<p><strong>Humorous Take from an Old Trader<\/strong>: &#8220;Trading MDWD is like dating a brilliant scientist\u2014incredibly exciting but be prepared for unexpected experiments and the occasional explosion in the lab. The breakthroughs can be life-changing, but you need asbestos gloves and a fire extinguisher handy!&#8221;<\/p>\n<h2>\u2705 How to Buy MediWound Ltd. (MDWD) Shares &#8211; Step by Step<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"0\">\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NASDAQ access and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Verification<\/td>\n<td>Typically requires ID and proof of address<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit Funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;MDWD&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control your entry price<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and Confirm<\/td>\n<td>Check commission fees and total cost<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor Your Position<\/td>\n<td>Set price alerts for important levels<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for New Investors<\/h2>\n<p>For those looking to invest in MediWound Ltd. (MDWD) stock, Pocket Option offers several advantages that are particularly beneficial for beginners:<\/p>\n<ul>\n<li><strong>Lowest Minimum Deposit<\/strong>: With just $5 required to start, you can test your investment strategy with minimal risk while still gaining exposure to promising companies like MediWound.<\/li>\n<li><strong>Rapid Verification<\/strong>: The platform&#8217;s streamlined KYC process accepts any single government ID, allowing you to start trading within minutes rather than days.<\/li>\n<li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods ensure you can access your profits conveniently, whether you prefer crypto, e-wallets, or traditional banking.<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes it ideal for investors who want to focus on company analysis rather than navigating complex trading systems.<\/p>\n<h2>\ud83c\udf0d MediWound in 2025: Innovation Leader in Wound Care<\/h2>\n<p>MediWound stands at the forefront of enzymatic wound care technology, with its flagship product NexoBrid already generating significant revenue and its investigational therapy EscharEx showing tremendous promise in clinical trials. The company&#8217;s strategic partnerships with industry giants like ConvaTec and Essity provide validation and reduce commercialization risk.<\/p>\n<p><strong>Current Market Position<\/strong>: MediWound controls innovative technology in the $2.5 billion chronic wound debridement market, with products that have demonstrated superiority over existing treatments in clinical trials (<a href=\"https:\/\/mediwound.com\/wp-content\/uploads\/2025\/08\/MDWD-corporate-deck-August-2025-1.pdf\">Corporate Presentation<\/a>).<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: MediWound&#8217;s manufacturing expansion isn&#8217;t just about capacity\u2014it&#8217;s about precision. Their new facility uses AI-driven quality control systems that can detect microscopic variations in enzyme consistency, ensuring every batch meets exact medical standards. This technological edge could become their secret weapon against larger competitors!<\/p>\n"},"faq":[{"question":"What is MediWound's main product?","answer":"NexoBrid is their commercial enzymatic debridement agent for severe burns, while EscharEx is their investigational therapy for chronic wounds like diabetic ulcers."},{"question":"How much cash does MediWound have?","answer":"As of Q2 2025, they have $32.9 million in cash reserves, providing approximately 16-18 months of runway."},{"question":"When is the next important catalyst for MDWD stock?","answer":"November 25, 2025\u2014Q3 earnings release\u2014and mid-2026 when EscharEx Phase III data is expected."},{"question":"Is MediWound profitable?","answer":"Not currently\u2014they're investing heavily in R&D and manufacturing expansion, which is typical for growth-stage biotech companies."},{"question":"What makes MediWound different from other wound care companies?","answer":"Their enzymatic approach offers precision debridement without surgery, representing a paradigm shift in wound care treatment."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is MediWound's main product?","answer":"NexoBrid is their commercial enzymatic debridement agent for severe burns, while EscharEx is their investigational therapy for chronic wounds like diabetic ulcers."},{"question":"How much cash does MediWound have?","answer":"As of Q2 2025, they have $32.9 million in cash reserves, providing approximately 16-18 months of runway."},{"question":"When is the next important catalyst for MDWD stock?","answer":"November 25, 2025\u2014Q3 earnings release\u2014and mid-2026 when EscharEx Phase III data is expected."},{"question":"Is MediWound profitable?","answer":"Not currently\u2014they're investing heavily in R&D and manufacturing expansion, which is typical for growth-stage biotech companies."},{"question":"What makes MediWound different from other wound care companies?","answer":"Their enzymatic approach offers precision debridement without surgery, representing a paradigm shift in wound care treatment."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy MediWound Ltd. (MDWD) shares - Investment in MediWound Ltd. (MDWD) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy MediWound Ltd. (MDWD) shares - Investment in MediWound Ltd. (MDWD) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T10:22:30+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy MediWound Ltd. (MDWD) shares &#8211; Investment in MediWound Ltd. (MDWD) stock\",\"datePublished\":\"2025-08-29T10:22:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\",\"name\":\"How to buy MediWound Ltd. (MDWD) shares - Investment in MediWound Ltd. (MDWD) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-29T10:22:30+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy MediWound Ltd. (MDWD) shares &#8211; Investment in MediWound Ltd. (MDWD) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy MediWound Ltd. (MDWD) shares - Investment in MediWound Ltd. (MDWD) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/","og_locale":"en_US","og_type":"article","og_title":"How to buy MediWound Ltd. (MDWD) shares - Investment in MediWound Ltd. (MDWD) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T10:22:30+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy MediWound Ltd. (MDWD) shares &#8211; Investment in MediWound Ltd. (MDWD) stock","datePublished":"2025-08-29T10:22:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/","name":"How to buy MediWound Ltd. (MDWD) shares - Investment in MediWound Ltd. (MDWD) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-29T10:22:30+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-mediwound\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy MediWound Ltd. (MDWD) shares &#8211; Investment in MediWound Ltd. (MDWD) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":357458,"slug":"how-to-buy-mediwound","post_title":"Comment acheter des actions MediWound Ltd. (MDWD) - Investissement dans les actions MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-mediwound\/"},"it_IT":{"locale":"it_IT","id":357459,"slug":"how-to-buy-mediwound","post_title":"Come acquistare azioni MediWound Ltd. (MDWD) - Investire in azioni MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-mediwound\/"},"pl_PL":{"locale":"pl_PL","id":357456,"slug":"how-to-buy-mediwound","post_title":"Jak kupi\u0107 akcje MediWound Ltd. (MDWD) - Inwestycja w akcje MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-mediwound\/"},"es_ES":{"locale":"es_ES","id":357460,"slug":"how-to-buy-mediwound","post_title":"C\u00f3mo comprar acciones de MediWound Ltd. (MDWD) - Inversi\u00f3n en acciones de MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-mediwound\/"},"th_TH":{"locale":"th_TH","id":357463,"slug":"how-to-buy-mediwound","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 MediWound Ltd. (MDWD) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-mediwound\/"},"tr_TR":{"locale":"tr_TR","id":357457,"slug":"how-to-buy-mediwound","post_title":"MediWound Ltd. (MDWD) Hisseleri Nas\u0131l Al\u0131n\u0131r - MediWound Ltd. (MDWD) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-mediwound\/"},"vt_VT":{"locale":"vt_VT","id":357461,"slug":"how-to-buy-mediwound","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu MediWound Ltd. (MDWD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-mediwound\/"},"pt_AA":{"locale":"pt_AA","id":357462,"slug":"how-to-buy-mediwound","post_title":"Como comprar a\u00e7\u00f5es da MediWound Ltd. (MDWD) - Investimento em a\u00e7\u00f5es da MediWound Ltd. (MDWD)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-mediwound\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/357370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=357370"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/357370\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=357370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=357370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=357370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}